title: Functions of ectopically transplanted invasive horse trophoblast.
abstract: The invasive and fully antigenic trophoblast of the chorionic girdle portion of the equine fetal membranes has the capacity to survive and differentiate after transplantation to ectopic sites. The objectives of this study were to determine i) the survival time of ectopically transplanted allogeneic trophoblast cells in non-pregnant recipient mares, ii) whether equine chorionic gonadotropin (eCG) can be delivered systemically by transplanted chorionic girdle cells, and iii) whether eCG delivered by the transplanted cells is biologically active and can suppress behavioral signs associated with estrus. Ectopically transplanted chorionic girdle survived for up to 105 days with a mean lifespan of 75 days (95% confidence interval 55-94) and secreted sufficient eCG for the hormone to be measurable in the recipients' circulation. Immunohistochemical labeling of serial biopsies of the transplant sites and measurement of eCG profiles demonstrated that graft survival was similar to the lifespan of equine endometrial cups in normal horse pregnancy. The eCG secreted by the transplanted cells induced corpora lutea formation and sustained systemic progesterone levels in the recipient mares, effects that are also observed during pregnancy. This in turn caused suppression of estrus behavior in the recipients for up to 3 months. Thus, ectopically transplanted equine trophoblast provides an unusual example of sustained viability and function of an immunogenic transplant in a recipient with an intact immune system. This model highlights the importance of innate immunoregulatory capabilities of invasive trophoblast cells and describes a new method to deliver sustained circulating concentrations of eCG in non-pregnant mares.
authors.affiliation: College of Veterinary Medicine, Baker Institute for Animal Health, Cornell University, Ithaca, New York 14853, USA.
authors.forename: Amanda M
authors.initials: AM
authors.lastname: de Mestre
authors.forename: David
authors.initials: D
authors.lastname: Hanlon
authors.forename: A Paige
authors.initials: AP
authors.lastname: Adams
authors.forename: Erin
authors.initials: E
authors.lastname: Runcan
authors.forename: Jane C
authors.initials: JC
authors.lastname: Leadbeater
authors.forename: Hollis N
authors.initials: HN
authors.lastname: Erb
authors.forename: Christina C
authors.initials: CC
authors.lastname: Costa
authors.forename: Donald
authors.initials: D
authors.lastname: Miller
authors.forename: W R
authors.initials: WR
authors.lastname: Allen
authors.forename: Douglas F
authors.initials: DF
authors.lastname: Antczak
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001706:Biopsy; D002470:Cell Survival; D006063:Chorionic Gonadotropin / Q000096:biosynthesis / Q000097:blood; D004971:Estrus / Q000378:metabolism; D005260:Female; D006085:Graft Survival; D006736:Horses; D007150:Immunohistochemistry; D012726:Sexual Behavior, Animal; D013997:Time Factors; D014184:Transplantation, Homologous; D014327:Trophoblasts / Q000276:immunology / Q000378:metabolism / Q000637:transplantation*; D014844:Vulva / Q000276:immunology / Q000378:metabolism / Q000601:surgery*
chemical_list: D006063:Chorionic Gonadotropin